Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Finasteride effectively treats male hair loss, increasing length and thickness.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Finasteride use during early pregnancy may cause limb deformities in babies.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Italian guidelines recommend using trichoscopy for diagnosis and treatments like minoxidil for hair loss.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Finasteride 1mg linked to diverse symptoms; other treatments improve erectile function in rats.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Finasteride may worsen blood sugar control in diabetic patients.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

More research needed to confirm finasteride as standard treatment for FFA.

The document discusses new insights into how hormones affect male sexual health and related conditions.